Dr. Harriet Belding Eldredge-Hindy, MD

Dr. Eldredge-Hindy practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Eldredge-Hindy's NPI, 1629395223, was assigned on April 23, 2010. Dr. Eldredge-Hindy holds South Carolina license 85108.

Dr. Eldredge-Hindy's primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Eldredge-Hindy's primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Eldredge-Hindy is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Eldredge-Hindy to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eldredge-Hindy practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Eldredge-Hindy's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Eldredge-Hindy's licenses on file in 4 states: South Carolina, Kentucky, Massachusetts and Pennsylvania.

CMS data shows 1,636 Medicare services from Dr. Eldredge-Hindy across 18 procedure codes in 2024, for 302 Medicare patients. Medicare paid $103,599 for them.

CMS counts 302 Medicare patients who saw Dr. Eldredge-Hindy in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have cancer, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Eldredge-Hindy's median patient age at 69, with 43% women.

In 2024, Dr. Eldredge-Hindy wrote 330 Medicare Part D claims for 71 patients. 62% of them were for generic drugs. CMS names the drug for 255 of them, across 5 drugs with 11 or more claims each, at $310,279 in total drug cost. In 2023, CMS named 109 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Eldredge-Hindy for performance year 2024, reported as part of a group. Dr. Eldredge-Hindy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eldredge-Hindy as offering telehealth.

Dmand AI links 26 papers to Dr. Eldredge-Hindy, published from 2014 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Brachytherapy, Breast Neoplasms and Mastectomy, Segmental. Dr. Eldredge-Hindy has published most often in Brachytherapy. Dr. Eldredge-Hindy's most frequent co-authors are Adam P. Dicker, MD, Daniel Stewart Metzinger, MD and Scott Richard Silva, MD, PhD.

Dmand AI links Dr. Eldredge-Hindy to 3 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Lobular and Vaginal Neoplasms.

CMS Open Payments shows 105 general payments to Dr. Eldredge-Hindy from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $617.